ELVN Enliven Therapeutics, Inc.
Nasdaq · SEC CIK 1672619 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $76.73M 38 sales by 9 insiders
- Filings on record
- 300 since 2021-07-01, latest 2026-09-21 17:23
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| ORBIMED ADVISORS LLC | 10% | — | $51.68M |
| Derynck Mika K | Dir | — | $9.56M |
| Collins Helen Louise | Chief MEDICAL Off | — | $5.39M |
| Lyssikatos Joseph P | CSO | — | $4.88M |
| Patel Anish | COO | — | $1.74M |
| Hohl Benjamin | CFO | — | $1.60M |
| Kunkel Lori Anne | Dir | — | $850.3K |
| Kintz Samuel | Pres AND CEO, Dir | — | $613.6K |
| Heyman Richard A. | Dir | — | $413.4K |
Transactions 332
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-04-15 | 2024-04-11 | ELVN | Collins Helen Louise | Chief MEDICAL Off | M - OptEx | $2.48 | +20.0K | 20.0K | New | +$49.6K |
| D | 2024-04-15 | 2024-04-11 | ELVN | Collins Helen Louise | Chief MEDICAL Off | S - Sale+OE | $25.07 | -20.0K | 0 | -100% | -$501.4K |
| M | 2024-04-15 | 2024-04-11+ | ELVN | Heyman Richard A. | Dir | S - Sale | $24.02 | -6,315 | 137.2K | -4% | -$151.7K |
| I | 2024-04-15 | 2024-04-11 | ELVN | Heyman Richard A. | Dir | S - Sale | $25.00 | -649 | 28.6K | -2% | -$16.2K |
| D | 2024-04-15 | 2024-04-11 | ELVN | Patel Anish | COO | S - Sale+OE | $25.03 | -17.5K | 0 | -100% | -$438.0K |
| D | 2024-04-15 | 2024-04-11 | ELVN | Patel Anish | COO | M - OptEx | $2.48 | +14.9K | 17.5K | +574% | +$37.0K |
| D | 2024-04-15 | 2024-04-11 | ELVN | Hohl Benjamin | CFO | M - OptEx | $2.48 | +14.0K | 14.0K | New | +$34.7K |
| DM | 2024-04-15 | 2024-04-11 | ELVN | Hohl Benjamin | CFO | S - Sale+OE | $24.73 | -14.0K | 0 | -100% | -$346.2K |
| D | 2024-04-15 | 2024-04-11 | ELVN | Lyssikatos Joseph P | CSO, Dir | S - Sale+OE | $25.04 | -30.0K | 0 | -100% | -$751.2K |
| D | 2024-04-15 | 2024-04-11 | ELVN | Lyssikatos Joseph P | CSO, Dir | M - OptEx | $1.12 | +30.0K | 30.0K | New | +$33.6K |
| D | 2024-04-15 | 2024-04-11 | ELVN | Kintz Samuel | Pres AND CEO, Dir | M - OptEx | $1.12 | +47.7K | 47.7K | New | +$53.4K |
| D | 2024-04-15 | 2024-04-11 | ELVN | Kintz Samuel | Pres AND CEO, Dir | S - Sale+OE | $25.04 | -47.7K | 0 | -100% | -$1.19M |
| DM | 2024-04-12 | 2024-04-10+ | ELVN | Ballal Rahul D. | Dir | M - OptEx | $13.08 | +67.0K | 75.7K | +767% | +$876.6K |
| DM | 2024-04-12 | 2024-04-10+ | ELVN | Ballal Rahul D. | Dir | S - Sale+OE | $23.36 | -67.0K | 45.4K | -60% | -$1.57M |
| M | 2024-04-10 | 2024-04-08 | ELVN | Patel Anish | COO | S - Sale | $18.60 | -4,875 | 2,597 | -65% | -$90.7K |
| D | 2024-04-08 | 2024-04-04 | ELVN | Ballal Rahul D. | Dir | S - Sale+OE | $19.15 | -3,485 | 22.3K | -13% | -$66.7K |
| D | 2024-04-08 | 2024-04-04 | ELVN | Ballal Rahul D. | Dir | M - OptEx | $12.60 | +3,485 | 25.8K | +16% | +$43.9K |
| DM | 2024-04-03 | 2024-04-01 | ELVN | Lyssikatos Joseph P | CSO, Dir | S - Sale+OE | $18.59 | -12.0K | 9,648 | -55% | -$223.1K |
| D | 2024-04-03 | 2024-04-01 | ELVN | Lyssikatos Joseph P | CSO, Dir | M - OptEx | $1.12 | +12.0K | 12.0K | New | +$13.4K |
| DM | 2024-04-03 | 2024-04-01 | ELVN | Ballal Rahul D. | Dir | M - OptEx | $5.73 | +3,237 | 25.6K | +14% | +$18.5K |
| D | 2024-04-03 | 2024-04-01 | ELVN | Ballal Rahul D. | Dir | S - Sale+OE | $19.08 | -3,237 | 22.3K | -13% | -$61.8K |
| DM | 2024-03-29 | 2024-03-27 | ELVN | Hohl Benjamin | CFO | S - Sale+OE | $18.25 | -3,250 | 182 | -95% | -$59.3K |
| D | 2024-03-29 | 2024-03-27 | ELVN | Hohl Benjamin | CFO | M - OptEx | $2.48 | +3,250 | 3,250 | New | +$8,060 |
| DM | 2024-03-27 | 2024-03-25 | ELVN | Kintz Samuel | Pres AND CEO, Dir | S - Sale+OE | $17.56 | -12.0K | 0 | -100% | -$210.7K |
| D | 2024-03-27 | 2024-03-25 | ELVN | Kintz Samuel | Pres AND CEO, Dir | M - OptEx | $1.12 | +12.0K | 12.0K | New | +$13.4K |
| D | 2024-03-22 | 2024-03-20 | ELVN | Ballal Rahul D. | Dir | M - OptEx | $5.52 | +13.3K | 35.6K | +59% | +$73.3K |
| D | 2024-03-22 | 2024-03-20 | ELVN | Ballal Rahul D. | Dir | S - Sale+OE | $19.16 | -13.3K | 22.3K | -37% | -$254.4K |
| 2024-03-21 | 2024-03-19 | ELVN | Heyman Richard A. | Dir | S - Sale | $14.50 | -1,270 | 143.5K | -0.9% | -$18.4K | |
| 2024-03-08 | 2024-03-06 | ELVN | Patel Anish | COO | S - Sale | $15.64 | -4,875 | 7,472 | -39% | -$76.2K | |
| DM | 2024-03-04 | 2024-02-29 | ELVN | Lyssikatos Joseph P | CSO, Dir | S - Sale+OE | $16.42 | -12.0K | 0 | -100% | -$197.0K |
| D | 2024-03-04 | 2024-02-29 | ELVN | Lyssikatos Joseph P | CSO, Dir | M - OptEx | $1.12 | +12.0K | 12.0K | New | +$13.4K |
| D | 2024-02-29 | 2024-02-27 | ELVN | Hohl Benjamin | CFO | S - Sale+OE | $16.97 | -3,250 | 0 | -100% | -$55.2K |
| D | 2024-02-29 | 2024-02-27 | ELVN | Hohl Benjamin | CFO | M - OptEx | $2.48 | +3,250 | 3,250 | New | +$8,060 |
| DM | 2024-02-28 | 2024-02-26 | ELVN | Kintz Samuel | Pres AND CEO, Dir | S - Sale+OE | $16.89 | -12.0K | 4,376 | -73% | -$202.7K |
| D | 2024-02-28 | 2024-02-26 | ELVN | Kintz Samuel | Pres AND CEO, Dir | M - OptEx | $1.12 | +12.0K | 12.0K | New | +$13.4K |
| 2024-02-20 | 2024-02-15 | ELVN | Heyman Richard A. | Dir | S - Sale | $17.42 | -1,270 | 144.7K | -0.9% | -$22.1K | |
| MI | 2024-02-16 | 2024-02-14 | ELVN | 5AM Ventures VI, L.P. | 10% | S - Sale | $14.90 | -825.0K | 3.20M | -20% | -$12.29M |
| 2024-02-08 | 2024-02-06 | ELVN | Patel Anish | COO | S - Sale | $15.11 | -4,875 | 12.3K | -28% | -$73.7K | |
| MI | 2024-02-02 | 2024-01-31 | ELVN | 5AM Opportunities I (GP), LLC | 10% | S - Sale | $15.00 | -500.0K | 772.0K | -39% | -$7.50M |
| 2024-02-01 | 2024-01-30 | ELVN | Heyman Richard A. | Dir | S - Sale | $16.41 | -1,270 | 146.0K | -0.9% | -$20.8K | |
| D | 2024-01-31 | 2024-01-29 | ELVN | Lyssikatos Joseph P | CSO, Dir | S - Sale+OE | $15.85 | -12.0K | 0 | -100% | -$190.2K |
| D | 2024-01-31 | 2024-01-29 | ELVN | Lyssikatos Joseph P | CSO, Dir | M - OptEx | $1.12 | +12.0K | 12.0K | New | +$13.4K |
| D | 2024-01-31 | 2024-01-29 | ELVN | Hohl Benjamin | CFO | S - Sale+OE | $15.81 | -3,250 | 0 | -100% | -$51.4K |
| D | 2024-01-31 | 2024-01-29 | ELVN | Hohl Benjamin | CFO | M - OptEx | $2.48 | +3,250 | 3,250 | New | +$8,060 |
| DM | 2024-01-29 | 2024-01-25 | ELVN | Kintz Samuel | Pres, CEO, Dir | S - Sale+OE | $15.69 | -12.0K | 0 | -100% | -$188.3K |
| D | 2024-01-29 | 2024-01-25 | ELVN | Kintz Samuel | Pres, CEO, Dir | M - OptEx | $1.12 | +12.0K | 12.0K | New | +$13.4K |
| 2024-01-24 | 2024-01-22 | ELVN | Patel Anish | COO | S - Sale | $15.14 | -4,875 | 17.2K | -22% | -$73.8K | |
| D | 2024-01-03 | 2023-12-29 | ELVN | Lyssikatos Joseph P | CSO, Dir | M - OptEx | $1.12 | +12.0K | 12.0K | New | +$13.4K |
| DM | 2024-01-03 | 2023-12-29 | ELVN | Lyssikatos Joseph P | CSO, Dir | S - Sale+OE | $14.28 | -12.0K | 0 | -100% | -$171.4K |
| DM | 2024-01-02 | 2023-12-28+ | ELVN | Hohl Benjamin | CFO | M - OptEx | $2.48 | +11.9K | 9,383 | New | +$29.4K |
| DM | 2024-01-02 | 2023-12-28+ | ELVN | Hohl Benjamin | CFO | S - Sale+OE | $15.02 | -11.9K | 0 | -100% | -$178.3K |
| M | 2024-01-02 | 2023-12-28+ | ELVN | Patel Anish | COO | S - Sale | $15.01 | -13.5K | 22.1K | -38% | -$203.3K |
| D | 2023-12-28 | 2023-12-26 | ELVN | Kintz Samuel | Pres, CEO, Dir | S - Sale+OE | $14.64 | -12.0K | 0 | -100% | -$175.7K |
| D | 2023-12-28 | 2023-12-26 | ELVN | Kintz Samuel | Pres, CEO, Dir | M - OptEx | $1.12 | +12.0K | 12.0K | New | +$13.4K |
| M | 2023-12-27 | 2023-12-22+ | ELVN | Patel Anish | COO | S - Sale | $15.03 | -1,085 | 35.6K | -3% | -$16.3K |
| DM | 2023-12-27 | 2023-12-22+ | ELVN | Hohl Benjamin | CFO | S - Sale+OE | $15.06 | -1,130 | 0 | -100% | -$17.0K |
| DM | 2023-12-27 | 2023-12-22+ | ELVN | Hohl Benjamin | CFO | M - OptEx | $2.48 | +1,130 | 100 | New | +$2,802 |
| DM | 2023-12-26 | 2023-12-21+ | ELVN | Lyssikatos Joseph P | CSO, Dir | S - Sale+OE | $13.07 | -6,566 | 0 | -100% | -$85.8K |
| DM | 2023-12-26 | 2023-12-21+ | ELVN | Lyssikatos Joseph P | CSO, Dir | M - OptEx | $1.12 | +6,566 | 20 | New | +$7,354 |
| DM | 2023-12-26 | 2023-12-21+ | ELVN | Kintz Samuel | Pres, CEO, Dir | M - OptEx | $1.12 | +8,195 | 8,175 | New | +$9,178 |
| DM | 2023-12-26 | 2023-12-21+ | ELVN | Kintz Samuel | Pres, CEO, Dir | S - Sale+OE | $13.05 | -8,195 | 0 | -100% | -$106.9K |
| M | 2023-12-26 | 2023-12-21+ | ELVN | Heyman Richard A. | Dir | S - Sale | $13.00 | -175 | 147.4K | -0.1% | -$2,275 |
| MI | 2023-12-26 | 2023-12-21+ | ELVN | Heyman Richard A. | Dir | S - Sale | $13.00 | -41 | 29.3K | -0.1% | -$533 |
| D | 2023-12-21 | 2023-12-20 | ELVN | Kintz Samuel | Pres, CEO, Dir | S - Sale+OE | $13.01 | -7,779 | 0 | -100% | -$101.2K |
| D | 2023-12-21 | 2023-12-20 | ELVN | Kintz Samuel | Pres, CEO, Dir | M - OptEx | $1.12 | +7,779 | 7,779 | New | +$8,712 |
| DM | 2023-12-21 | 2023-12-19+ | ELVN | Lyssikatos Joseph P | CSO, Dir | M - OptEx | $1.12 | +8,888 | 8,688 | New | +$9,955 |
| DM | 2023-12-21 | 2023-12-19+ | ELVN | Lyssikatos Joseph P | CSO, Dir | S - Sale+OE | $13.01 | -8,888 | 0 | -100% | -$115.6K |
| M | 2023-12-21 | 2023-12-19+ | ELVN | Heyman Richard A. | Dir | S - Sale | $13.02 | -2,365 | 147.5K | -2% | -$30.8K |
| I | 2023-12-21 | 2023-12-20 | ELVN | Heyman Richard A. | Dir | S - Sale | $13.02 | -1,915 | 29.3K | -6% | -$24.9K |
| D | 2023-11-06 | 2023-11-03 | ELVN | Kintz Samuel | Pres, CEO, Dir | S - Sale+OE | $13.08 | -8,026 | 0 | -100% | -$105.0K |
| D | 2023-11-06 | 2023-11-03 | ELVN | Kintz Samuel | Pres, CEO, Dir | M - OptEx | $1.12 | +8,026 | 8,026 | New | +$8,989 |
| D | 2023-11-06 | 2023-11-03 | ELVN | Lyssikatos Joseph P | CSO, Dir | S - Sale+OE | $13.08 | -8,546 | 0 | -100% | -$111.8K |
| D | 2023-11-06 | 2023-11-03 | ELVN | Lyssikatos Joseph P | CSO, Dir | M - OptEx | $1.12 | +8,546 | 8,546 | New | +$9,572 |
| D | 2023-10-03 | 2023-09-29 | ELVN | Lyssikatos Joseph P | CSO, Dir | S - Sale+OE | $13.62 | -12.0K | 0 | -100% | -$163.4K |
| D | 2023-10-03 | 2023-09-29 | ELVN | Lyssikatos Joseph P | CSO, Dir | M - OptEx | $1.12 | +12.0K | 12.0K | New | +$13.4K |
| MI | 2023-09-28 | 2023-09-26 | ELVN | 5AM Opportunities I, L.P. | 10% | S - Sale | $15.00 | -197.5K | 854.8K | -19% | -$2.96M |
| D | 2023-09-26 | 2023-09-25 | ELVN | Kintz Samuel | Pres, CEO, Dir | S - Sale+OE | $13.81 | -12.0K | 0 | -100% | -$165.7K |
| D | 2023-09-26 | 2023-09-25 | ELVN | Kintz Samuel | Pres, CEO, Dir | M - OptEx | $1.12 | +12.0K | 12.0K | New | +$13.4K |
| MI | 2023-08-28 | 2023-08-24 | ELVN | Schwab Andrew J. | 10% | S - Sale | $16.00 | -440.0K | 4.47M | -9% | -$7.04M |
| DI | 2023-05-19 | 2023-05-17 | ELVN | Gupta Rishi | Dir, 10% | M - OptEx | $4.28 | +2,125 | 8.66M | +0.0% | +$9,095 |
| DI | 2023-05-19 | 2023-05-17 | ELVN | OrbiMed Capital GP VII LLC | Dir, 10% | M - OptEx | $4.28 | +2,125 | 8.66M | +0.0% | +$9,095 |
| MI | 2023-02-27 | 2023-02-23 | ELVN | Gupta Rishi | Dir, 10% | A - Grant | — | +7.90M | 288.1K | New | — |
| MI | 2023-02-27 | 2023-02-23 | ELVN | OrbiMed Genesis GP LLC | 10% | A - Grant | — | +7.90M | 8.66M | +1,037% | — |
| I | 2023-02-27 | 2023-02-23 | ELVN | Kolchinsky Peter | Former 10% owner | A - Grant | — | +1.15M | 2.12M | +119% | — |
| D | 2023-02-27 | 2023-02-23 | ELVN | Patel Anish | COO | A - Grant | — | +36.7K | 36.7K | New | — |
| DI | 2023-02-27 | 2023-02-23 | ELVN | Patel Anish | COO | A - Grant | — | +394.0K | 394.0K | New | — |
| D | 2023-02-27 | 2023-02-23 | ELVN | Bauer Jake | Dir | A - Grant | — | +87.4K | 87.4K | New | — |
| DI | 2023-02-27 | 2023-02-23 | ELVN | Lyssikatos Joseph P | CSO, Dir | A - Grant | — | +1.12M | 1.12M | New | — |
| DMI | 2023-02-27 | 2023-02-23 | ELVN | Kintz Samuel | Pres, CEO, Dir | A - Grant | — | +1.26M | 1.09M | New | — |
| D | 2023-02-27 | 2023-02-23 | ELVN | Heyman Richard A. | Dir | A - Grant | — | +149.8K | 149.8K | New | — |
| DMI | 2023-02-27 | 2023-02-23 | ELVN | Heyman Richard A. | Dir | A - Grant | — | +68.6K | 31.2K | New | — |
| MI | 2023-02-27 | 2023-02-23 | ELVN | Schwab Andrew J. | Dir | A - Grant | — | +5.80M | 960.4K | New | — |
| I | 2023-02-27 | 2023-02-23 | ELVN | COMMODORE CAPITAL LP | 10% | P - Purchase | $22.07 | +621.75 | 718.7K | +0.1% | +$13.7K |
| I | 2023-02-27 | 2023-02-23 | ELVN | COMMODORE CAPITAL LP | 10% | J - Other | — | +729.9K | 1.45M | +102% | — |
| MI | 2023-02-23 | 2023-02-21+ | ELVN | COMMODORE CAPITAL LP | 10% | P - Purchase | $5.15 | +31.8K | 2.87M | +1% | +$163.4K |
| 2023-02-22 | 2023-02-22 | ELVN | Ballal Rahul D. | CEO | S - Sale | $4.66 | -32.9K | 87.8K | -27% | -$153.1K | |
| 2023-02-22 | 2023-02-22 | ELVN | GRAY MICHAEL | CFO, COO | S - Sale | $4.67 | -9,856 | 27.6K | -26% | -$46.0K | |
| 2023-02-01 | 2023-01-30 | ELVN | GRAY MICHAEL | CFO, COO | S - Sale | $3.92 | -3,596 | 37.5K | -9% | -$14.1K | |
| 2023-02-01 | 2023-01-30 | ELVN | Ballal Rahul D. | CEO | S - Sale | $3.91 | -11.3K | 120.7K | -9% | -$44.2K | |
| AI | 2023-01-05 | 2023-01-03 | ELVN | Leonard Braden Michael | 10% | S - Sale | $4.00 | -1.25M | 1.77M | -41% | -$5.00M |
Purchase Sale Sale after option exercise All abbreviations